Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: A systematic review

Expert Review of Neurotherapeutics

Volumn 13, Issue 1, 2013, Pages 49-73

  Rucklidge, Julia J ^a   Kaplan, Bonnie J ^b  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

ADHD; autism; depression; micronutrients; minerals; psychiatric; psychosis; review; treatment; vitamins

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ASCORBIC ACID PLUS VITAMIN B COMPLEX; BIOFLAVONOID; BIOTIN; CENTRUM; CHOLINE BITARTRATE; CNE; COPPER; CYANOCOBALAMIN; EFALEX; EMPOWERPLUS; EXECUTIVE B ACTIVE; FOLIC ACID; FORCEVAL; GEGORVIT; INOSITOL; IRON; KIDDI; MANGANESE; MARINE; MINERAL; MULTIBIONTA; MULTIVITAMIN; NICOTINAMIDE; PLACEBO; PLANT EXTRACT; POTASSIUM; PYRIDOXINE; RECIP AB; RETINOL; RIBOFLAVIN; SAAVE; SELENIUM; SPECTRUM SUPPORT; SUPRADYN; THIAMINE; TRACE ELEMENT; TROPAMINE; ULTIVITE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN; ZINC;

ALCOHOLISM; ALERTNESS; ANOREXIA; ANTISOCIAL BEHAVIOR; ANXIETY; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CASE CONTROL STUDY; CLINICAL TRIAL (TOPIC); COCAINE DEPENDENCE; COGNITION; DIET SUPPLEMENTATION; DRUG FORMULATION; DYSTHYMIA; EXECUTIVE FUNCTION; HUMAN; MENTAL CONCENTRATION; MENTAL DISEASE; MENTAL STRESS; MOOD; MOOD CHANGE; POSTTRAUMATIC STRESS DISORDER; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

ANTIPSYCHOTIC AGENTS; DATABASES, FACTUAL; HUMANS; MENTAL DISORDERS; MICRONUTRIENTS; MINERALS; VITAMINS;

EID: 84871575948     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.12.143     Document Type: Review

References (114)

1. Ritter T. The People's Home Medical Book. Barnum, OH, USA (1910).
2. Kaplan BJ, Crawford SG, Field CJ, Simpson JS. Vitamins, minerals, and mood. Psychol. Bull. 133(5), 747-760 (2007).
3. Sarris J, Mischoulon D, Schweitzer I. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Bipolar Disord. 13(5-6), 454-465 (2011).
4. Rucklidge JJ, Johnstone J, Kaplan BJ. Nutrient supplementation approaches in the treatment of ADHD. Expert Rev. Neurother. 9(4), 461-476 (2009).
5. Benton D. The impact of diet on anti-social, violent and criminal behaviour. Neurosci. Biobehav. Rev. 31(5), 752-774 (2007).
6. Teaford MF, Ungar PS. Diet and the evolution of the earliest human ancestors. Proc. Natl Acad. Sci. USA 97(25), 13506-13511 (2000).
7. Mertz W. A balanced approach to nutrition for health: the need for biologically essential minerals and vitamins. J. Am. Diet. Assoc. 94(11), 1259-1262 (1994).
8. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293(9), 1082-1088 (2005).
9. Chen K, Zhang X, Li TY et al. Effect of vitamin A, vitamin A plus iron and multiple micronutrient-fortified seasoning powder on infectious morbidity of preschool children. Nutrition 27(4), 428-434 (2011).
10. Remington R, Chan A, Paskavitz J, Shea TB. Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study. Am. J. Alzheimers. Dis. Other Demen. 24(1), 27-33 (2009).
11. Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms. Am. J. Clin. Nutr. 75(4), 616-658 (2002).
12. Huskisson E, Maggini S, Ruf M. The influence of micronutrients on cognitive function and performance. J. Int. Med. Res. 35(1), 1-19 (2007).
13. Almeida OP, McCaul K, Hankey GJ, Norman P, Jamrozik K, Flicker L. Homocysteine and depression in later life. Arch. Gen. Psychiatry 65(11), 1286-1294 (2008).
14. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ. Homocysteine, B vitamin status, and cognitive function in the elderly. Am. J. Clin. Nutr. 75(5), 908-913 (2002).
15. Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J. Alzheimers Dis. 29(1), 133-149 (2012).
16. McNally L, Bhagwagar Z, Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 13(6), 501-510 (2008).
17. Young LT. Is bipolar disorder a mitochondrial disease? J. Psychiatry Neurosci. 32(3), 160-161 (2007).
18. Russell VA, Oades RD, Tannock R et al. Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis. Behav. Brain Funct. 2, 30 (2006).
19. Gardner A, Boles RG. Is a 'mitochondrial psychiatry' in the future? A review. Curr. Psychiatr. Rev. 1, 255-271 (2005).
20. Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 17(3), 290-314 (2012).
21. Parikh S, Saneto R, Falk MJ et al. A modern approach to the treatment of mitochondrial disease. Curr. Treat. Options Neurol. 11(6), 414-430 (2009).
22. Jackson JR, Eaton WW, Cascella NG, Fasano A, Kelly DL. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr. Q. 83(1), 91-102 (2012).
23. Katz M, Levine AA, Kol-Degani H, Kav-Venaki L. A compound herbal preparation (CHP) in the treatment of children with ADHD: a randomized controlled trial. J. Atten. Disord. 14(3), 281-291 (2010).
24. Kaplan BJ, Giesbrecht G, Shannon S, McLeod K. Evaluating treatments in health care: the instability of a one-legged stool. BMC Med. Res. Methodol. 11, 65 (2011).
25. Blampied NM. Single-case research designs and the scientist-practitioner ideal in applied psychology. In: APA Handbook of Behavior Analysis. Madden G (Ed.). American Psychological Association, DC, USA (2012).
26. Frensham LJ, Bryan J, Parletta N. Influences of micronutrient and ω-3 fatty acid supplementation on cognition, learning, and behavior: methodological considerations and implications for children and adolescents in developed societies. Nutr. Rev. 70(10), 594-610 (2012).
27. Grima NA, Pase MP, Macpherson H, Pipingas A. The effects of multivitamins on cognitive performance: a systematic review and meta-analysis. J. Alzheimers Dis. 29(3), 561-569 (2012).
28. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med. 6(7), e1000097 (2009).
29. Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology 32(2), 98-105 (1995).
30. Heseker H, Kübler W, Pudel V, Westenhöffer J. Psychological disorders as early symptoms of a mild-to-moderate vitamin deficiency. Ann. N. Y. Acad. Sci. 669, 352-357 (1992).
31. Harris E, Kirk J, Rowsell R et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum. Psychopharmacol. 26(8), 560-567 (2011).
32. Nguyen PH, Grajeda R, Melgar P et al. Micronutrient supplementation may reduce symptoms of depression in Guatemalan women. Arch. Latinoam. Nutr. 59(3), 278-286 (2009).
33. Haskell CF, Scholey AB, Jackson PA et al. Cognitive and mood effects in healthy children during 12 weeks' supplementation with multi-vitamin/minerals. Br. J. Nutr. 100(5), 1086-1096 (2008).
34. Neri M, Andermarcher E, Pradelli JM, Salvioli G. Influence of a double blind pharmacological trial on two domains of well-being in subjects with age associated memory impairment. Arch. Gerontol. Geriatr. 21(3), 241-252 (1995).
35. Cockle SM, Haller J, Kimber S, Dawe RA, Hindmarch I. The influence of multivitamins on cognitive function and mood in the elderly. Aging Ment. Health 4(4), 339-353 (2000).
36. America A, Milling LS. The efficacy of vitamins for reducing or preventing depression symptoms in healthy individuals: natural remedy or placebo? J. Behav. Med. 31(2), 157-167 (2008).
37. Gosney MA, Hammond MF, Shenkin A, Allsup S. Effect of micronutrient supplementation on mood in nursing home residents. Gerontology 54(5), 292-299 (2008).
38. Gariballa S, Forster S. Effects of dietary supplements on depressive symptoms in older patients: a randomised double-blind placebo-controlled trial. Clin. Nutr. 26(5), 545-551 (2007).
39. Manders M, De Groot LC, Hoefnagels WH et al. The effect of a nutrient dense drink on mental and physical function in institutionalized elderly people. J. Nutr. Health Aging 13(9), 760-767 (2009).
40. Kaplan BJ, Simpson JS, Ferre RC, Gorman CP, McMullen DM, Crawford SG. Effective mood stabilization with a chelated mineral supplement: an open-label trial in bipolar disorder. J. Clin. Psychiatry 62(12), 936-944 (2001).
41. Popper CW. Do vitamins or minerals (apart from lithium) have mood-stabilizing effects? J. Clin. Psychiatry 62(12), 933-935 (2001).
42. Simmons M. Nutritional approach to bipolar disorder. J. Clin. Psychiatry 64(3), 338; author reply 338-338; author reply 339 (2003).
43. Frazier EA, Fristad MA, Arnold LE. Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders. J. Altern. Complement. Med. 18(7), 678-685 (2012).
44. Kaplan BJ, Crawford SG, Gardner B, Farrelly G. Treatment of mood lability and explosive rage with minerals and vitamins: two case studies in children. J. Child Adolesc. Psychopharmacol. 12(3), 205-219 (2002).
45. Gately D, Kaplan BJ. Database analysis of adults with bipolar disorder consuming a multinutrient formula. Clin. Med. Psychiatr. 4, 3-16 (2009).
46. Rucklidge JJ, Gately D, Kaplan BJ. Database analysis of children and adolescents with bipolar disorder consuming a multinutrient formula. BMC: Psychiatr. 74(10) (2010).
47. Australian Government. Nutrient Reference Values for Australia and New Zealand: Including Recommended Dietary Intakes. National Health and Medical Research Council, Department of Health and Ageing, Canberra, Australia (2006).
48. Schlebusch L, Bosch BA, Polglase G, Kleinschmidt I, Pillay BJ, Cassimjee MH. A double-blind, placebo-controlled, double-centre study of the effects of an oral multivitamin-mineral combination on stress. S. Afr. Med. J. 90(12), 1216-1223 (2000).
49. Carroll D, Ring C, Suter M, Willemsen G. The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: a doubleblind placebo-controlled trial. Psychopharmacology (Berl.) 150(2), 220-225 (2000).
50. Kennedy DO, Veasey R, Watson A et al. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology (Berl.) 211(1), 55-68 (2010).
51. Stough C, Scholey A, Lloyd J, Spong J, Myers S, Downey LA. The effect of 90 day administration of a high dose vitamin B-complex on work stress. Hum. Psychopharmacol. 26(7), 470-476 (2011).
52. Rucklidge JJ, Andridge R, Gorman B, Blampied N, Gordon H, Boggis A. Shaken but unstirred? Effects of micronutrients on stress and trauma after an earthquake: RCT evidence comparing formulas and doses. Hum. Psychopharmacol. 27(5), 440-454 (2012).
53. Rucklidge J, Johnstone J, Harrison R, Boggis A. Micronutrients reduce stress and anxiety in adults with attention-deficit/hyperactivity disorder following a 7.1 earthquake. Psychiatry Res. 189(2), 281-287 (2011).
54. Haskell CF, Robertson B, Jones E et al. Effects of a multi-vitamin/ mineral supplement on cognitive function and fatigue during extended multi tasking. Hum. Psychopharmacol. 25(6), 448-461 (2010).
55. Gruenwald J, Graubaum HJ, Harde A. Effect of a probiotic multivitamin compound on stress and exhaustion. Adv. Ther. 19(3), 141-150 (2002).
56. Rucklidge JJ. Successful treatment of OCD with a micronutrient formula following partial response to Cognitive Behavioral Therapy (CBT): a case study. J. Anxiety Disord. 23(6), 836-840 (2009).
57. Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. Br. J. Psychiatry 181, 22-28 (2002).
58. Zaalberg A, Nijman H, Bulten E, Stroosma L, van der Staak C. Effects of nutritional supplements on aggression, rule-breaking, and psychopathology among young adult prisoners. Aggress. Behav. 36(2), 117-126 (2010).
59. Schoenthaler SJ, Amos SP, Doraz WE et al. The effect of randomized vitamin-mineral supplementation on violent and non-violent antisocial behavior among incarcerated juveniles. J. Nutr. Environ. Med. 7, 343-352 (1997).
60. Schoenthaler SJ, Bier ID. The effect of vitamin-mineral supplementation on juvenile delinquency among American schoolchildren: a randomized, double-blind placebo-controlled trial. J. Altern. Complement. Med. 6(1), 7-17 (2000).
61. Blum K, Allison D, Trachtenberg MC, Williams RW, Loeblich LA. Reduction of both drug hunger and withdrawal against advice rate of cocaine abusers in a 30-day inpatient treatment program by the neuronutrient Tropamine. Curr. Ther. Res. 43(6), 1204-1214 (1988).
62. Chen TJ, Blum K, Chen AL et al. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map. J. Psychoactive Drugs 43(2), 108-127 (2011).
63. Guenther RM. The role of nutritional therapy in alcoholism treatment. Int. J. Biosoc. Res. 4(1), 5-18 (1983).
64. Brown RJ, Blum K, Trachtenberg MC. Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders. J. Psychoactive Drugs 22(2), 173-187 (1990).
65. Poulos CJ. What effects do corrective nutritional practices have on alcoholics? J. Orthomol. Psychiatr. 10(1), 61-64 (1981).
66. Harrison R, Rucklidge JJ, Blampied N. Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a reversal design: a case study. J. Psychoactive Drugs 32(3):422-427 (2012).
67. Chen D, Liu Y, He W, Wang H, Wang Z. Neurotransmitter-precursor- supplement intervention for detoxified heroin addicts. J. Huazhong Univ. Sci. Technol. Med. Sci. 32(3), 422-427 (2012).
68. Arnold LE. Treatment alternatives for attention-deficit/hyperactivity disorder (ADHD). J. Atten. Disord. 3(1), 30-48 (1999).
69. Kaplan BJ, Fisher JE, Crawford SG, Field CJ, Kolb B. Improved mood and behavior during treatment with a mineral-vitamin supplement: an open-label case series of children. J. Child Adolesc. Psychopharmacol. 14(1), 115-122 (2004).
70. Rucklidge J, Taylor M, Whitehead K. Effect of micronutrients on behavior and mood in adults With ADHD: evidence from an 8-week open label trial with natural extension. J. Atten. Disord. 15(1), 79-91 (2011).
71. Rucklidge JJ, Harrison R. Successful treatment of bipolar disorder II and ADHD with a micronutrient formula: a case study. CNS Spectr. 15(5), 289-295 (2010).
72. Harding KL, Judah RD, Gant C. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Altern. Med. Rev. 8(3), 319-330 (2003).
73. Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J. Dev. Behav. Pediatr. 28(2), 82-91 (2007).
74. Vazir S, Nagalla B, Thangiah V, Kamasamudram V, Bhattiprolu S. Effect of micronutrient supplement on health and nutritional status of schoolchildren: mental function. Nutrition 22(1 Suppl.), S26-S32 (2006).
75. Curtis LT, Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J. Altern. Complement. Med. 14(1), 79-85 (2008).
76. Rossignol DA. Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann. Clin. Psychiatry 21(4), 213-236 (2009).
77. Adams JB, Holloway C. Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J. Altern. Complement. Med. 10(6), 1033-1039 (2004).
78. Adams JB, Audhya T, McDonough-Means S et al. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 11, 111 (2011).
79. Mehl-Madrona L, Leung B, Kennedy C, Paul S, Kaplan BJ. Micronutrients versus standard medication management in autism: a naturalistic case-control study. J. Child Adolesc. Psychopharmacol. 20(2), 95-103 (2010).
80. MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder. Behav. Brain Res. 217(1), 47-54 (2011).
81. Hoffer LJ. Vitamin therapy in schizophrenia. Isr. J. Psychiatry Relat. Sci. 45(1), 3-10 (2008).
82. McCreadie RG, Kelly C, Connolly M et al. Dietary improvement in people with schizophrenia: randomised controlled trial. Br. J. Psychiatry 187, 346-351 (2005).
83. Joshi VG, Eswaran S. Vitamins B1, B6, and B12 in the adjunctive treatment of schizophrenia. J. Orthomol. Psychiatr. 9(1), 35-40 (1980).
84. Ban TA, Lehmann HE, Deutsch M. Negative findings with megavitamins in schizophrenic patients: preliminary report. Commun. Psychopharmacol. 1(2), 119-122 (1977).
85. Vaughan K, McConaghy N. Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial. Aust. N. Z. J. Psychiatry 33(1), 84-88 (1999).
86. Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr. Res. 62(3), 195-204 (2003).
87. Frazier EA, Fristad MA, Arnold LE. Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder. J. Child Adolesc. Psychopharmacol. 19(4), 453-460 (2009).
88. Rodway M, Vance A, Watters A et al. Efficacy and cost of micronutrient treatment of childhood psychosis. BMJ Case Reports pii, 1-7 (2012).
89. Amminger GP, Schäfer MR, Papageorgiou K et al. Long-chain ω-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry 67(2), 146-154 (2010).
90. McIntyre RS, Jerrell JM. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Arch. Pediatr. Adolesc. Med. 162(10), 929-935 (2008).
91. Ayton AK, Azaz A, Horrobin DF. Rapid improvement of severe anorexia nervosa during treatment with ethyl-eicosapentaenoate and micronutrients. Eur. Psychiatry 19(5), 317-319 (2004).
92. Simon GE, Cherkin DC, Sherman KJ, Eisenberg DM, Deyo RA, Davis RB. Mental health visits to complementary and alternative medicine providers. Gen. Hosp. Psychiatry 26(3), 171-177 (2004).
93. Martin A, Young C, Leckman JF, Mukonoweshuro C, Rosenheck R, Leslie D. Age effects on antidepressant-induced manic conversion. Arch. Pediatr. Adolesc. Med. 158(8), 773-780 (2004).
94. Tonkin A, Jureidini J. Wishful thinking: antidepressant drugs in childhood depression. Br. J. Psychiatry 187, 304-305 (2005).
95. Henin A, Mick E, Biederman J et al. Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth? J. Clin. Psychiatry 70(8), 1178-1185 (2009).
96. Simpson JS, Crawford SG, Goldstein ET, Field C, Burgess E, Kaplan BJ. Systematic review of safety and tolerability of a complex micronutrient formula used in mental health. BMC Psychiatry 11, 62 (2011).
97. Benton D. To establish the parameters of optimal nutrition do we need to consider psychological in addition to physiological parameters? Mol. Nutr. Food Res. doi:10.1002/mnfr.201200477 (2012) (Epub ahead of print).
98. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142(1), 37-46 (2005).
99. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2, CD007176 (2008).
100. Williams RJ. Biochemical Individuality: The Basis for the Genetotrophic Concept. Keats, CT, USA (1998).
101. Jacka FN, Pasco JA, Mykletun A et al. Association of western and traditional diets with depression and anxiety in women. Am. J. Psychiatry 167(3), 305-311 (2010).
102. Kuijer RG, Boyce JA. Emotional eating and its effect on eating behaviour after a natural disaster. Appetite 58(3), 936-939 (2012).
103. Galler JR, Bryce CP, Zichlin ML, Fitzmaurice G, Eaglesfield GD, Waber DP. Infant malnutrition is associated with persisting attention deficits in middle adulthood. J. Nutr. 142(4), 788-794 (2012).
104. Galler JR, Bryce CP, Waber D et al. Early childhood malnutrition predicts depressive symptoms at ages 11-17. J. Child Psychol. Psychiatry. 51(7), 789-798 (2010).
105. Oddy WH, Robinson M, Ambrosini GL et al. The association between dietary patterns and mental health in early adolescence. Prev. Med. 49(1), 39-44 (2009).
106. Sánchez-Villegas A, Delgado-Rodríguez M, Alonso A et al. Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch. Gen. Psychiatry 66(10), 1090-1098 (2009).
107. Sánchez-Villegas A, Toledo E, de Irala J, Ruiz-Canela M, Pla-Vidal J, Martínez-González MA. Fast-food and commercial baked goods consumption and the risk of depression. Public Health Nutr. 15(3), 424-432 (2012).
108. Molina BS, Hinshaw SP, Swanson JM et al.; MTA Cooperative Group. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J. Am. Acad. Child Adolesc. Psychiatry 48(5), 484-500 (2009).
109. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and safety of antidepressants for children and adolescents. BMJ 328(7444), 879-883 (2004).
110. Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 11, 22 (2011).
111. Knowles SR, Nelson EA, Palombo EA. Investigating the role of perceived stress on bacterial flora activity and salivary cortisol secretion: a possible mechanism underlying susceptibility to illness. Biol. Psychol. 77(2), 132-137 (2008).
112. Messaoudi M, Lalonde R, Violle N et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 105(5), 755-764 (2011).
113. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain Behav. Immun. 24(1), 9-16 (2010).
114. Stevenson J, Sonuga-Barke E, McCann D et al. The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children's ADHD symptoms. Am. J. Psychiatry 167(9), 1108-1115 (2010).